Schizophrenia Clinical Trial
Official title:
Implementing Effective, Collaborative Care for Schizophrenia
This project evaluates the implementation and effectiveness of a care model to improve treatment for schizophrenia within the context of diverse VA practices and priorities. The project provides information to VA clinicians and managers about Veterans with schizophrenia or schizoaffective disorder who are overweight and/or who would like to return to competitive work. The project facilitates reorganization of care practices in order to get veterans needed and desired services around wellness and work. The project creates a platform that other clinical and research interventions can build upon to improve care, and is designed to inform a national strategy for implementing evidence-based care in schizophrenia.
Objectives:
EQUIP-2 is a clinic-level controlled trial. From the four participating Veterans Integrated
Services Networks (VISNs), eight specialty mental health programs were enrolled and assigned
to care as usual or to receive an intervention supporting evidence-based quality improvement
and use of a chronic illness care model. Participants are VISN 3 (James J. Peters VA;
Northport VA); VISN 16 (Houston VA; Shreveport VA); VISN 17 (Waco VA; Temple VA); and VISN 22
(Long Beach VA; Greater Los Angeles VA). The objectives of this VA Quality Enhancement
Research Initiative (QUERI) Service Directed Project are 1) assist in identifying and making
available recovery-oriented services to veterans with schizophrenia; 2) implement information
systems that efficiently and accurately identify patient status and who would be appropriate
for these services; 3) implement a care model to support recovery-oriented care delivery; 4)
evaluate, in a controlled trial, the effect of implementation on treatment delivery and
patient outcomes; and 5) identify facilitators and barriers to wellness program participation
in an effort to strengthen the weight management services available to patients with
schizophrenia. The project studies intervention feasibility, acceptability, and impact on
outcomes; performs qualitative analyses examining processes and variation in care model
implementation and impact. Research includes a controlled trial of the impact of
implementation, relative to usual care, on treatment quality. Participants include clinic
staff and patients with schizophrenia. Data sources include interviews with participants,
focus groups with a sub-set of patients, implementation documentation, the project
informatics system, and VistA.
Methods:
The care model targets two clinical domains selected by the VISNs from the following:
Supported Employment (SE), caregiver support, wellness programs, or clozapine. All 4 VISNs
chose the same two targets: SE and wellness. The care model includes: 1) at each visit,
routine collection of patient outcomes data and provision of decision support using a
self-assessment kiosk; 2) provision of "psychiatric vital signs" to patients and clinicians
at the time of the clinical encounter via report that prints from the kiosk; 3) education and
activation of both clinicians and patients around the clinical targets; 4) regular reports
identifying patients appropriate for services associated with these targets; and 5)
facilitation of problem-solving and evidence-based quality improvement addressing any
barriers to utilization of these services.
To inform future wellness implementation, in-depth, semi-structured interviews are conducted
with patients who participated in wellness groups ("participants"), and with patients who
were referred (because they were overweight or obese) but did not participate
("non-participants"). Participants consist of all enrolled patients who attended the wellness
program with special attention to those patients who completed at least half of the wellness
program. Non-participants consist of patients who were referred to the wellness program but
did not attend. Clinicians were interviewed specifically regarding wellness implementation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |